Zogenix, Inc. et al v. Apotex Inc. et al
| Zogenix, Inc. and Zogenix International Ltd. |
| Apotex Corp. |
| Apotex Inc. |
| 1:2021cv01533 |
| October 28, 2021 |
| US District Court for the District of Delaware |
| Richard G Andrews |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. § 271 Patent Infringement |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on March 9, 2023. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 13 NOTICE OF SERVICE of (1) Apotex's Objections to Plaintiffs' Rule 30(b)(1) Notice of Deposition to B. Bhupesh Singh; (2) Apotex's Objections to Plaintiffs' Rule 30(b)(1) Notice of Deposition to Larry Wang; (3) Apotex's Objections to Plaintiffs' 30(b)(1) Notice of Deposition to Mikhail Oulman; and (4) Apotex's Objections to Plaintiffs' 30(b)(1) Notice of Deposition to Phyllis Tsang filed by Apotex Corp., Apotex Inc..(Dorsney, Kenneth) |
| CORRECTING ENTRY: The Answer filed at D.I. 13, and Disclosure Statement filed at D.I. 14 on 1/3/2022, have been removed from the docket. All filings are to be made in Lead Civil Action 21-1252-RGA only (see D.I. #12 ). (nms) |
Filing 12
SO ORDERED Granting (D.I. 11 in 21-cv-1533-RGA; D.I. 17 in 21-cv-1252-RGA) Stipulated Order Regarding Waiving of Service, Establishment of Answer Deadlines, Consolidation of Actions, Adoption of Scheduling Order, and Adoption of Protective Order. Signed by Judge Richard G. Andrews on 12/21/2021. Associated Cases: 1:21-cv-01252-RGA, 1:21-cv-01533-RGA(nms)
|
| Filing 11 STIPULATION Regarding Consolidation of Actions by Zogenix International Ltd., Zogenix, Inc.. (Kraft, Denise) |
| Case Reassigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. Associated Cases: 1:21-cv-01252-RGA, 1:21-cv-01424-RGA, 1:21-cv-01533-RGA (rjb) |
|
Filing 10
ORDER: IT IS ORDERED that, on or before January 10, 2022, counsel for plaintiffs shall inform the court as to whether the need for coordinated discovery and/or Markman proceedings is anticipated as to the above cases and, if so, when a joint scheduling conference might most efficiently be conducted (*Notice of Compliance deadline set for 1/10/2022). Signed by Judge Colm F. Connolly on 12/13/2021. Associated Cases: 1:21-cv-01252-CFC, 1:21-cv-01424-CFC, 1:21-cv-01533-CFC(nmf) Modified on 12/15/2021 (nms).
|
| Pro Hac Vice Attorneys April Abele Isaacson, Stuart E. Pollack, Michael E. Furrow, and Kimberlynn B. Davis for Zogenix International Ltd. and Zogenix, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (twk) |
|
SO ORDERED, re #7 MOTION for Pro Hac Vice Appearance of Attorney Stuart E. Pollack, April Abele Isaacson, Michael E. Furrow and Kimberlynn B. Davis filed by Zogenix International Ltd., Zogenix, Inc. Signed by Judge Colm F. Connolly on 11/3/2021. (nmf)
|
| Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (nms) |
| Filing 9 WAIVER OF SERVICE returned executed by Zogenix, Inc., Zogenix International Ltd.: For Apotex Corp. waiver sent on 11/1/2021, answer due 1/3/2022. (Kraft, Denise) |
| Filing 8 WAIVER OF SERVICE returned executed by Zogenix, Inc., Zogenix International Ltd.: For Apotex Inc. waiver sent on 11/1/2021, answer due 1/3/2022. (Kraft, Denise) |
| Filing 7 MOTION for Pro Hac Vice Appearance of Attorney Stuart E. Pollack, April Abele Isaacson, Michael E. Furrow and Kimberlynn B. Davis - filed by Zogenix International Ltd., Zogenix, Inc.. (Attachments: #1 Text of Proposed Order, #2 Certification of Stuart E. Pollack, #3 Certification of April Abele Isaacson, #4 Certification of Michael E. Furrow, #5 Certification of Kimberlynn B. Davis)(Kraft, Denise) |
| Filing 6 Summons Issued with Magistrate Consent Notice attached as to Apotex Corp. on 10/28/2021. (myr) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Zogenix, Inc. for Zogenix International Ltd. Zogenix, Inc. has no parent corporation filed by Zogenix International Ltd., Zogenix, Inc. (myr) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,947,183 B2 ;10,950,331 B2. (myr) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: October 13, 2021. Date of Expiration of Patent: See Appendix. Thirty Month Stay Deadline:See Appendix. (myr) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (myr) |
| Filing 1 COMPLAINT filed against Apotex Corp., Apotex Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3731327.) - filed by Zogenix, Inc., Zogenix International Ltd. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Civil Cover Sheet)(myr) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
